Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/IO-BIOTECH-INC-129052295/attualita/IO-Biotech-completa-l-arruolamento-di-380-pazienti-nello-studio-pivotale-di-Fase-3-nel-melanoma-avan-45304963/?utm_source=whatsapp&utm_medium=social&utm_campaign=share